Page 7 - Ohnson Johnson News Today

The Omaha conglomerate made an investment in the company that controls Atlanta's baseball team after the Braves split from Liberty Media, a longtime Berkshire holding.

Warren Buffett and his team exited GM, J&J, P&G, UPS, and Mondelez last quarter, and kept one or more stock purchases under wraps.

By Karen E. Roman Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a company which develops biologic medicines, announced it has appointed Dorothy Clarke to its board of directors. Ms. Clarke previously held leadership roles at Johnson & Johnson for over two decades and specialized in law, regulatory affairs, compliance, and data protection, the company […]

Warren Buffett sold nearly $500 million of stocks in a 20-year period, and counted Walmart and Wells Fargo among his holdings, ProPublica reported.

Warren Buffett has said that doing so would present a conflict of interest and therefore he avoids such stocks

Subscription based models for the delivery of sanitary products have gained popularity. The services provide convenience and ensure a regular customer base.Wilmington, Delaware, United States, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc- The global sanitary napkin market was estimated to have acquired US$ 24.5 billion in 2021. It is anticipated to register a 5.0% CAGR from 2022 to 2031 and by 2031, the market is likely to gain US$ 41.0 billion. Innovations in absorption te

Since 2016, Johnson & Johnson has been hit with at least $570 million in damage awards over talc-related cancer claims and paid out at least $2.5 billion in settlements

A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday. There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago. “It is the first ever to show ant...

(Bloomberg) -- Johnson & Johnson is weighing a third attempt to use bankruptcy for an $8.9 billion settlement of tens of thousands of lawsuits that allege tainted talc in the company’s baby powder caused cancer, the health-care giant told investors Tuesday.Most Read from BloombergHundreds Dead at Gaza Hospital as Israel, Hamas Trade BlameIsrael Latest: Biden ‘Deeply Saddened’ Over Hospital BlastTreasury Yields Climb as Hot Data Fuel Fed Wagers: Markets WrapWill Xi Jinpi...

Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson’s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect […]